Aibili Logo Association for Innovation and Biomedical Research on Light

Ongoing Projects


Coimbra Coordinating Centre for Clinical Research

Characterization of Retinal vascular disease in eyes with mild to moderate NPDR in Diabetes type 2, using novel non-invasive Imaging methods, in a longitudinal and prospective clinical Study with 2 years of duration. (CORDIS, Protocol CEC010/2018) [more info]

Progression of Diabetic Retinopathy. Identification of Signs and Surrogate outcomes. (PROGRESS, Protocol CEC/007/16) [more info]

Characterization of potential biomarkers of Eye Disease and Vision Loss (EyeMarker). [more info]

Apoio na análise de dados e na elaboração de trabalhos científicos para estudos observacionais/retrospetivos da AIBILI/CHUC. (STAT) [more info]

Five-year incidence of Age-related Macular Degeneration in the central region of Portugal (AMDIncidence_CPT) [more info]

A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease (BETA3) [more info]

The longitudinal observational early markers study (LOBS) [more info]

A Randomized, Double-masked, Sham-controlled Phase 4 Study of the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in patients with Polypoidal Choroidal Vasculopathy (ATLANTIC). Protocol ECR-AMD-2015-09 [more info]

E3 Consortium to promote and sustain collaboration and sharing of data and knowledge in the field of ophthalmic epidemiology in Europe. E3 [more info]

An open label, registry study of the safety of ILUVIEN® fluocinoloneacetonide 190 micrograms intravitreal implant in applicator (IRISS). Protocol M-01-12-001 [more info]

Projects by department:

  -   Cloud   -  Copyright © AIBILI   -   Contact Us   -   Site Map   -   Privacy Policy  -  Cookies Policy  -  Webdesign Glitz Design   -   Programming Bizview